Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18794207 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Conditions: High Risk MC4R Genotype;   Low Risk MC4R Genotype;   One Week or Less Antipsychotic Lifetime Exposure
Interventions: Drug: Ziprasidone;   Drug: aripiprazole, quetiapine, or risperidone
2 Completed
Has Results
Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
Condition: Schizophrenia
Interventions: Drug: Risperidone;   Drug: Olanzapine (enrollment closed in this treatment);   Drug: Molindone

Indicates status has not been verified in more than two years